New Antifungal Drugs, New Approaches and Vaccines Antifungal name Choose antifungalAlbaconazoleAlpha-asaroneAmorolfineAR-12ASP2397 (VL-2397)ASP9726AuranofinAureobasidin ABHBMBiafungin (CD101)CD101Ceragenin CSA-131CorifunginE1210Encochleated AmB (MAT023)EV-086F901318 (olorofim)FG 3622FK506 (tacrolimus) and L-685,818FR290581General articlesGM 237354GriseofulvinHaemofunginIbomycinIbrexafungerp (SCY-078, MK-3118)Icofungipen (PLD-118)Ilicicolin HKOSN-2079 (polyketide)L365L743L884Macrocyclic amidinoureasManumycin AMAT2203MGCD290MycograbMyriocinNebulised AmpBNikkomycin ZNovamycin (NP339)Novexatin (NP213)P11-6PC945PolyoxinPradimicins (inc. BMS-181184)R-135853SampangineSM21SPK-843StatinsT-2307TacrolimusTavaborole (AN2690)TipifarnibTurbinmicinVaccinesVT-1129VT-1161VT-1598YO-001A Showing 10 posts of 219 posts found. Title Trail phase Date Activity of E901318 19 September 2015 Drug discovery 15 September 2015 Single Ascending Oral Dose Study of F901318 Phase 1 16 March 2015 F901318 Multiple Ascending Dose Study Phase 1 15 January 2015 F901318 Single Ascending Dose Study in Healthy Male Volunteers Phase 1 13 May 2014 FG-3622 Phase 1 6 July 2009 Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease Phase 2 24 November 2011 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Phase 2 8 July 2003 A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) Phase 1 30 July 2007 Efficacy Vulvovaginitis Candida Phase 2 13 September 2005 Previous1...78910111213141516171819202122Next
